7 September 2018, San Francisco: The global stereotactic surgery devices market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. Stereotactic surgery is a minimally invasive alternative for traditional invasive ablation and biopsy methods. Since, stereotactic surgery has various advantages such as higher efficacy, minimal or no surgical incisions, and lower risk of damage to healthy cells, it is replacing conventional radiotherapies. These surgical procedures have helped overcome drawbacks associated with traditional invasive surgeries, such as destruction of healthy cells and higher risk of recurrence & postoperative complications.
Only around 10.0% of the population in low and middle-income countries have access to radiation therapy, owing to dearth of radiation therapy devices. A market leader, Elekta, in its 2016 annual report stated that the number of installations of linear accelerators in high-income countries was approximately 13,000, whereas the requirement was around 25,000. Hence, huge demand-supply discrepancy of radiotherapy devices is likely to open new avenues for major market players in developing countries.
Access Research Report of Stereotactic Surgery Devices Market @: www.grandviewresearch.com/industry-analysis/stereotactic-surgery-devices-market
Further key findings from the study suggest:
- Linear accelerators (LINAC) accounted for the leading volume share in 2017, owing to higher affordability and larger commercial availability
- CyberKnife is poised to exhibit the fastest growth over the forecast period owing to their growing adoption in developing countries
- North America dominated the market in 2017 due to number of government initiatives focused on creating awareness regarding availability of advanced treatment options and presence of developed healthcare infrastructure
- Some of the major players operating in the market are Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Incorporated
- These players dominate the market with their strong brand identity and extensive geographical reach attained through various strategic initiatives such as mergers & acquisitions and partnership agreements.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global stereotactic surgery devices market on the basis of device type and region:
Stereotactic Surgery Devices Product Type Outlook (Revenue, USD Million, 2014 – 2025)
- Gamma Knife
- LINAC
- PBRT
- CyberKnife
Stereotactic Surgery Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)
- North America
- US.
- Canada
- Europe
- UK.
- Germany
- Greece
- Italy
- Spain
- France
- Belgium
- Sweden
- Asia Pacific
- Japan
- India
- China
- Australia
- Singapore
- South Korea
- Malaysia
- New Zealand
- Indonesia
- Hong Kong
- Latin America
- Mexico
- Brazil
- Argentina
- MEA
- Morocco
- Kuwait
- Iran
- South Africa
Access Press Release of Stereotactic Surgery Devices Market@: www.grandviewresearch.com/press-release/global-stereotactic-surgery-devices-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com